216 related articles for article (PubMed ID: 11988841)
1. Proteasomal degradation of human peptidyl prolyl isomerase pin1-pointing phospho Bcl2 toward dephosphorylation.
Basu A; Das M; Qanungo S; Fan XJ; DuBois G; Haldar S
Neoplasia; 2002; 4(3):218-27. PubMed ID: 11988841
[TBL] [Abstract][Full Text] [Related]
2. Signal-induced site specific phosphorylation targets Bcl2 to the proteasome pathway.
Basu A; Haldar S
Int J Oncol; 2002 Sep; 21(3):597-601. PubMed ID: 12168105
[TBL] [Abstract][Full Text] [Related]
3. Microtubule-targeting drugs induce bcl-2 phosphorylation and association with Pin1.
Pathan N; Aime-Sempe C; Kitada S; Basu A; Haldar S; Reed JC
Neoplasia; 2001; 3(6):550-9. PubMed ID: 11774038
[TBL] [Abstract][Full Text] [Related]
4. Microtubule-targeting drugs induce Bcl-2 phosphorylation and association with Pin1.
Pathan N; Aime-Sempe C; Kitada S; Haldar S; Reed JC
Neoplasia; 2001; 3(1):70-9. PubMed ID: 11326318
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation-dependent proline isomerization catalyzed by Pin1 is essential for tumor cell survival and entry into mitosis.
Rippmann JF; Hobbie S; Daiber C; Guilliard B; Bauer M; Birk J; Nar H; Garin-Chesa P; Rettig WJ; Schnapp A
Cell Growth Differ; 2000 Jul; 11(7):409-16. PubMed ID: 10939594
[TBL] [Abstract][Full Text] [Related]
6. The microtubule-targeting agents, PBOX-6 [pyrrolobenzoxazepine 7-[(dimethylcarbamoyl)oxy]-6-(2-naphthyl)pyrrolo-[2,1-d] (1,5)-benzoxazepine] and paclitaxel, induce nucleocytoplasmic redistribution of the peptidyl-prolyl isomerases, cyclophilin A and pin1, in malignant hematopoietic cells.
Bane FT; Bannon JH; Pennington SR; Campiani G; Williams DC; Zisterer DM; Mc Gee MM
J Pharmacol Exp Ther; 2009 Apr; 329(1):38-47. PubMed ID: 19131583
[TBL] [Abstract][Full Text] [Related]
7. Functional conservation of phosphorylation-specific prolyl isomerases in plants.
Yao JL; Kops O; Lu PJ; Lu KP
J Biol Chem; 2001 Apr; 276(17):13517-23. PubMed ID: 11118438
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation-dependent prolyl isomerization: a novel signaling regulatory mechanism.
Zhou XZ; Lu PJ; Wulf G; Lu KP
Cell Mol Life Sci; 1999 Nov; 56(9-10):788-806. PubMed ID: 11212339
[TBL] [Abstract][Full Text] [Related]
9. Peptidyl prolyl isomerase, Pin1 is a potential target for enhancing the therapeutic efficacy of etoposide.
Mathur R; Chandna S; N Kapoor P; S Dwarakanath B
Curr Cancer Drug Targets; 2011 Mar; 11(3):380-92. PubMed ID: 21247380
[TBL] [Abstract][Full Text] [Related]
10. The Peptidyl-Prolyl
Anto NP; Muraleedharan A; Nath PR; Sun Z; Keasar C; Livneh E; Braiman A; Altman A; Kong KF; Isakov N
Front Immunol; 2023; 14():1126464. PubMed ID: 36969236
[TBL] [Abstract][Full Text] [Related]
11. Prolyl isomerase Pin1 acts as a switch to control the degree of substrate ubiquitylation.
Siepe D; Jentsch S
Nat Cell Biol; 2009 Aug; 11(8):967-72. PubMed ID: 19597489
[TBL] [Abstract][Full Text] [Related]
12. Role of phosphorylation in determining the backbone dynamics of the serine/threonine-proline motif and Pin1 substrate recognition.
Schutkowski M; Bernhardt A; Zhou XZ; Shen M; Reimer U; Rahfeld JU; Lu KP; Fischer G
Biochemistry; 1998 Apr; 37(16):5566-75. PubMed ID: 9548941
[TBL] [Abstract][Full Text] [Related]
13. Binding of phosphatase inhibitor-2 to prolyl isomerase Pin1 modifies specificity for mitotic phosphoproteins.
Li M; Stukenberg PT; Brautigan DL
Biochemistry; 2008 Jan; 47(1):292-300. PubMed ID: 18062707
[TBL] [Abstract][Full Text] [Related]
14. Utilizing the peptidyl-prolyl cis-trans isomerase pin1 as a probe of its phosphorylated target proteins. Examples of binding to nuclear proteins in a human kidney cell line and to tau in Alzheimer's diseased brain.
Thorpe JR; Morley SJ; Rulten SL
J Histochem Cytochem; 2001 Jan; 49(1):97-108. PubMed ID: 11118482
[TBL] [Abstract][Full Text] [Related]
15. Prolyl isomerase Pin1 regulates cadmium-induced autophagy via ubiquitin-mediated post-translational stabilization of phospho-Ser GSK3αβ in human hepatocellular carcinoma cells.
So KY; Oh SH
Biochem Pharmacol; 2015 Dec; 98(3):511-21. PubMed ID: 26445356
[TBL] [Abstract][Full Text] [Related]
16. Interaction and structural modification of topoisomerase IIalpha by peptidyl prolyl isomerase, pin1: an in silico study.
Mathur R; Suman S; Beaume N; Ali M; Bhatt AN; Chopra M; Saluja D; Mishra AK; Chandna S; Kapoor PN; Dwarakanath BS
Protein Pept Lett; 2010 Feb; 17(2):151-63. PubMed ID: 20214639
[TBL] [Abstract][Full Text] [Related]
17. Oxygen-independent stabilization of HIF-2α in breast cancer through direct interaction with peptidyl-prolyl cis-trans isomerase NIMA-interacting 1.
Guillen-Quispe YN; Kim SJ; Saeidi S; Zhou T; Zheng J; Kim SH; Fang X; Chelakkot C; Rios-Castillo ME; Shin YK; Surh YJ
Free Radic Biol Med; 2023 Oct; 207():296-307. PubMed ID: 37473874
[TBL] [Abstract][Full Text] [Related]
18. Binding and regulation of the transcription factor NFAT by the peptidyl prolyl cis-trans isomerase Pin1.
Liu W; Youn HD; Zhou XZ; Lu KP; Liu JO
FEBS Lett; 2001 May; 496(2-3):105-8. PubMed ID: 11356192
[TBL] [Abstract][Full Text] [Related]
19. [Recent advances in the study of pin1 and its inhibitors].
Zhang CJ; Zhang ZH; Xu BL; Wang YL
Yao Xue Xue Bao; 2008 Jan; 43(1):9-17. PubMed ID: 18357725
[TBL] [Abstract][Full Text] [Related]
20. [Pin1: a multi-talented peptidyl prolyl cis-trans isomerase and a promising therapeutic target for human cancers].
Marsolier J; Weitzman JB
Med Sci (Paris); 2014; 30(8-9):772-8. PubMed ID: 25174754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
